Also, the increase in IL-1β secretion along with the simultaneous decrease in TGF-β1, IL-10, and CD206 levels suggest that the COX-2 inhibition could redirect macrophages towards a pro-inflammatory, anti-tumor M1 phenotype, opposing the effects of TMZ. This evidence concerns the gene TGFB1 and neoplasm.